|
|
|
Volumn 21, Issue 2, 2010, Pages 116-119
|
|
ACCORD LIPID study results strengthen guideline approach of adding fenofibrate to therapy of dyslipidaemic type 2 diabetic patients
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CREATININE;
FENOFIBRATE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
ANTILIPEMIC AGENT;
LIPID;
CONFERENCE PAPER;
DIABETIC NEPHROPATHY;
DRUG SAFETY;
DYSLIPIDEMIA;
HUMAN;
MICROALBUMINURIA;
MYALGIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RHABDOMYOLYSIS;
ARTICLE;
BLOOD;
ORGANIZATION;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
TREATMENT OUTCOME;
ANTILIPEMIC AGENTS;
CONGRESSES AS TOPIC;
DIABETES MELLITUS, TYPE 2;
DYSLIPIDEMIAS;
GUIDELINE ADHERENCE;
HUMANS;
LIPIDS;
PRACTICE GUIDELINES AS TOPIC;
PROCETOFEN;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
|
EID: 77951603365
PISSN: 19951892
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (1)
|
